Survival Outcomes According to Molecular Classification of Uterine Carcinosarcoma


Michael D. Toboni, MD, MPH1, Kaitlyn Kincaid, MD1, Sharon Wu, PhD2, Tyler Mattox, PhD2, Matthew J. Oberley, MD2, Premal H. Thaker, MD3, Matthew A. Powell, MD3, Nathaniel Jones, MD4


Uterine carcinosarcoma (UCS) is an aggressive cancer with a poor prognosis.

• There are limited studies evaluating the molecular stratification of UCS or its association with survival outcomes.

• No survival comparisons exist between UCS and endometrioid endometrial cancer (EEC) according to molecular classification.

Download Publication